“Media experiences explain it like a loophole,” suggests Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s extremely intentional coverage.” Brunner has expressed aggravation regarding how some coverage on the increase of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medicines or study peptides with credentialed operations https://shermank753jmv1.blogdanica.com/profile